Nifty
Sensex
:
:
11765.05
40200.56
-2.70 (-0.02%)
55.06 (0.14%)

Pharmaceuticals & Drugs

Rating :
43/99  (View)

BSE: 524500 | NSE: KILITCH

90.30
-2.75 (-2.96%)
27-Oct-2020 | 9:29AM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  90.30
  •  90.30
  •  90.30
  •  93.05
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  36
  •  0.03
  •  142.50
  •  61.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 151.54
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 161.35
  • N/A
  • 1.31

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 68.70%
  • 0.43%
  • 27.72%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 3.15%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -9.60
  • 20.50
  • 1.49

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -25.47
  • -70.26
  • -26.83

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -22.36
  • -
  • -45.36

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.36
  • -
  • 48.68

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.86
  • 1.20
  • 1.61

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.27
  • -0.79
  • 5.11

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
10
10
-2%
12
19
-40%
16
8
89%
15
27
-43%
Expenses
11
11
1%
14
16
-15%
14
12
20%
14
22
-39%
EBITDA
-1
-1
-
-2
3
-
2
-4
-
2
4
-61%
EBIDTM
-11%
-7%
-20%
15%
10%
-42%
11%
17%
Other Income
0
1
-73%
1
-1
-
1
0
109%
1
2
-69%
Interest
0
0
93%
0
0
-39%
0
0
0
0
0
0
Depreciation
0
0
11%
1
1
-5%
1
1
13%
0
1
-12%
PBT
-2
0
-
-2
1
-
1
-4
-
2
6
-71%
Tax
0
0
-
0
1
-
1
1
-52%
0
2
-79%
PAT
-1
0
-
-1
0
-
1
-5
-
1
4
-68%
PATM
-13%
-2%
-11%
3%
6%
-57%
9%
16%
EPS
-0.86
-0.12
-
-0.80
0.32
-
0.61
-3.11
-
0.86
2.71
-68%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 12
Mar 11
Mar 10
Net Sales
53
53
82
51
29
21
19
108
146
143
Net Sales Growth
-18%
-35%
62%
78%
36%
10%
-82%
-26%
3%
 
Cost Of Goods Sold
30
29
48
26
11
9
7
71
100
98
Gross Profit
23
24
34
25
17
12
12
37
46
44
GP Margin
44%
45%
42%
49%
61%
58%
63%
34%
31%
31%
Total Expenditure
53
53
76
46
29
25
21
95
124
119
Power & Fuel Cost
-
2
1
1
1
1
1
6
7
5
% Of Sales
-
3%
2%
2%
4%
5%
4%
6%
4%
3%
Employee Cost
-
6
5
4
3
3
3
6
6
4
% Of Sales
-
11%
6%
8%
12%
17%
16%
6%
4%
3%
Manufacturing Exp.
-
4
3
2
3
3
2
6
8
7
% Of Sales
-
7%
3%
4%
10%
13%
9%
6%
5%
5%
General & Admin Exp.
-
6
5
3
3
3
3
2
2
2
% Of Sales
-
12%
6%
6%
10%
13%
13%
2%
1%
1%
Selling & Distn. Exp.
-
6
9
5
5
3
2
2
1
2
% Of Sales
-
12%
10%
10%
16%
16%
11%
2%
1%
1%
Miscellaneous Exp.
-
1
5
4
3
3
4
1
1
1
% Of Sales
-
2%
6%
7%
11%
16%
19%
1%
1%
1%
EBITDA
0
0
6
5
-1
-4
-2
13
22
24
EBITDA Margin
0%
0%
7%
10%
-2%
-20%
-9%
12%
15%
17%
Other Income
3
5
5
3
1
3
3
1
0
0
Interest
1
1
1
0
0
0
0
3
4
5
Depreciation
2
2
2
2
10
10
2
5
6
6
PBT
0
2
9
6
-9
-12
-1
6
13
14
Tax
0
1
5
1
0
0
-1
21
3
3
Tax Rate
1,600%
48%
55%
16%
5%
4%
69%
22%
20%
21%
PAT
0
1
4
5
-9
-11
0
77
11
11
PAT before Minority Interest
0
1
4
5
-9
-11
0
76
10
11
Minority Interest
0
0
0
0
0
0
0
1
0
0
PAT Margin
-1%
2%
5%
10%
-31%
-53%
-2%
71%
7%
8%
PAT Growth
0%
-78%
-26%
158%
21%
-3,759%
-100%
628%
-2%
 
EPS
-0.19
0.54
2.47
3.32
-5.74
-7.22
-0.19
49.59
6.81
6.93

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 12
Mar 11
Mar 10
Shareholder's Funds
118
121
112
101
109
120
115
84
75
Share Capital
15
15
14
13
13
13
13
13
13
Total Reserves
102
105
95
87
94
105
100
69
60
Non-Current Liabilities
-1
-1
-2
-2
-1
-1
1
1
38
Secured Loans
0
0
0
0
0
0
0
0
43
Unsecured Loans
0
0
0
0
0
0
0
0
0
Long Term Provisions
0
0
0
0
0
0
0
0
0
Current Liabilities
22
20
15
12
8
7
60
66
21
Trade Payables
7
4
8
6
4
2
4
10
12
Other Current Liabilities
1
4
4
3
3
4
1
38
2
Short Term Borrowings
13
9
1
1
0
0
9
16
0
Short Term Provisions
1
2
3
2
1
1
47
2
7
Total Liabilities
142
143
126
110
116
126
177
153
135
Net Block
32
32
33
33
42
9
9
42
44
Gross Block
71
69
68
66
66
23
21
74
71
Accumulated Depreciation
39
37
35
33
23
13
12
32
27
Non Current Assets
86
78
63
62
68
79
10
85
67
Capital Work in Progress
30
20
3
1
0
0
0
43
22
Non Current Investment
24
25
26
27
26
47
1
0
1
Long Term Loans & Adv.
0
0
0
0
0
23
0
0
0
Other Non Current Assets
1
0
1
1
0
0
0
0
0
Current Assets
56
65
63
49
47
47
167
68
67
Current Investments
28
28
30
26
23
25
138
0
0
Inventories
6
5
3
3
3
2
2
17
12
Sundry Debtors
16
19
21
15
16
13
15
39
48
Cash & Bank
3
8
5
2
3
5
12
9
4
Other Current Assets
4
0
0
0
2
2
1
2
3
Short Term Loans & Adv.
4
4
4
3
2
2
0
1
3
Net Current Assets
34
45
48
37
39
40
107
1
46
Total Assets
142
143
126
110
116
126
177
153
135

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 12
Mar 11
Mar 10
Cash From Operating Activity
4
0
1
1
17
-8
-29
22
12
PBT
2
9
6
-9
-12
-1
-10
13
14
Adjustment
-2
2
2
11
9
2
7
9
7
Changes in Working Capital
6
-6
-7
-1
20
-9
-27
0
-5
Cash after chg. in Working capital
6
4
1
1
17
-8
-29
22
15
Interest Paid
0
0
0
0
0
0
0
0
0
Tax Paid
-2
-4
0
0
0
0
0
0
-3
Other Direct Exp. Paid
0
0
0
0
0
0
0
0
0
Extra & Other Items
0
0
0
0
0
0
0
0
0
Cash From Investing Activity
-10
-14
-4
-2
-20
-31
41
-24
-20
Net Fixed Assets
-1
-2
-1
-1
-1
-2
97
-24
Net Investments
2
1
-4
-4
-20
68
-138
-1
Others
-11
-13
1
3
1
-98
82
1
Cash from Financing Activity
2
17
6
0
0
0
-9
7
7
Net Cash Inflow / Outflow
-5
3
2
0
-2
-39
2
6
-1
Opening Cash & Equivalents
8
5
2
3
5
44
9
4
5
Closing Cash & Equivalent
3
8
5
2
3
5
12
9
4

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 12
Mar 11
Mar 10
Book Value (Rs.)
76
78
79
75
81
90
86
62
55
ROA
1%
3%
4%
-8%
-9%
0%
46%
7%
8%
ROE
1%
3%
5%
-9%
-10%
0%
78%
14%
15%
ROCE
2%
8%
6%
-9%
-10%
-1%
77%
13%
15%
Fixed Asset Turnover
0.76
1.20
0.76
0.44
0.48
0.88
2.33
2.05
2.01
Receivable days
121
89
126
197
252
265
89
106
123
Inventory Days
35
17
19
33
44
45
32
36
32
Payable days
42
32
59
53
37
70
26
31
35
Cash Conversion Cycle
114
73
86
178
259
240
94
111
119
Total Debt/Equity
0.11
0.08
0.01
0.01
0.00
0.00
0.08
0.64
0.59
Interest Cover
3
14
16
-59
-183
-18
34
5
4

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.